EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 20:15 ET (23-Jun-2026 00:15 GMT/UTC)

Study is first to detect, track multiple cancer-causing viruses in wastewater

Baylor College of Medicine
Peer-Reviewed Publication

This study is the first comprehensive approach to detect all known cancer-causing or oncogenic viruses concurrently by analyzing viral genomes in wastewater. The work, a collaboration between Baylor College of Medicine and the University of Texas Health Science Center at Houston, shows that it is feasible to monitor the presence and levels of cancer-causing viruses, enabling the possibility of public health interventions in the future.

Journal: Applied and Environmental Microbiology

UT MD Anderson shares latest research breakthroughs

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

New targeted and combination therapies show strong clinical promise

Breakthrough biomarkers and genomic tools enable earlier detection and better prediction of treatment response

Novel therapeutic strategies show promise in treating aggressive cancers

Tumor markers shown to guide prognosis and postoperative monitoring

Missing patient information in SEER database may create “blind spots” in cancer data

American College of Surgeons
Peer-Reviewed Publication

The SEER database may be missing information on high-risk, underserved patients that can make overall outcomes appear better than reality.

Journal: Journal of the American College of Surgeons

American Society for Radiation Oncology (ASTRO) to host Annual Meeting in Boston, September 26-30

American Society for Radiation Oncology
Meeting Announcement

Registration opens today for the 68^th American Society for Radiation Oncology (ASTRO) Annual Meeting, the leading global conference in radiation oncology. The conference will be held at the Thomas M. Menino Convention & Exhibition Center in Boston, September 26-30, 2026. Complimentary media registration is available for qualified journalists.

New marker aids diagnosis for aggressive prostate cancer

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due to a loss of traditional prostatic markers, according to researchers at The University of Texas MD Anderson Cancer Center.

Journal: Histopathology

Rare extraluminal esophageal cancer invades spine despite normal endoscopy

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — May 14, 2026 — A new case report was published in Volume 13 of Oncoscience on March 19, 2026, titled “Unprecedented non-luminal esophageal adenocarcinoma invading the spine.”

Journal: Oncoscience

Novel tool enables high-precision, low-cost pediatric leukemia diagnostics

Elsevier
Peer-Reviewed Publication

Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer, compared to other publicly available fusion detection algorithms. The tool, detailed in an article appearing in The Journal of Molecular Diagnostics, published by Elsevier, enables a higher diagnostic yield from low-coverage, low-cost sequencing.

Journal: Journal of Molecular Diagnostics
Funder: Hyundai Hope On Wheels, Reelin’ for Research

Nanotechnology special issue spotlights smart platforms while advancing precision cancer therapy

China Anti-Cancer Association
Peer-Reviewed Publication

Nanotechnology is emerging as a transformative force in cancer research, but the future of precision oncology will not be defined by drug delivery alone.

Journal: Cancer Biology & Medicine

Influenza virus platforms: New hope for vaccines and cancer immunotherapy

Higher Education Press
Peer-Reviewed Publication

Influenza viruses, long known as harmful human pathogens, are now being reengineered into safe and powerful therapeutic tools. A new article in Engineering introduces a controllable PTC influenza platform using non-canonical amino acids to limit viral replication while boosting immune protection. This versatile system works as a next-generation vaccine against flu and other infections and shows strong potential as a cancer immunotherapy tool, opening new paths for future infectious disease and cancer treatments.

Journal: Engineering

Bobba receives Young Investigator Award for prostate cancer research

University of Tennessee at Knoxville
Grant and Award Announcement

Nuclear Engineering Assistant Professor Kondapa Naidu Bobba at the University of Tennessee, Knoxville has been selected to receive the 2026 Young Investigator Award, which is jointly supported by the Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) to advance important prostate cancer research among early-career physicians and scientists.

43
44
45
46
47